Media Articles

ICON’s Marie McCarthy, Pavel Lebesle, and Matthew McCarty discuss how to accelerate drug development for patients with rare diseases in this Pharmafile article.

Read this MPO Magazine article written by ICON expert Vicki Anastasi on how value-based healthcare (VBHC) models are expected to transform the health sector.

Read this article to learn how to improve the efficiency of trial designs & procedures throughout the drug development process.

Discover the top digital & tech developments in the life science industry, including mHealth, AI, robotic process automation, blockchain & virtual tech.

Discover the importance of specialist epidemiology knowledge, due to their specialised focus on pharmacoepidemiological study design, to ensure robust and reliable downstream study findings.

E.B. McLindon explains how ICON is taking a different approach with its Integrated Site Network in this Scrip 100 media article.

The cost challenges presented by precision medicine in rare disease, and the strategies that can be employed to overcome them.

An article discussing ICON's unmatched global reach & expertise in oncology & work with Pfizer.

A thought leadership article by Martin Lachs, Olivier Saulin and Chris Learn on how CROs can best support increasing demand for ACT clinical trials.

An article featuring commentary from Ciarán Murray on his achievement of being awarded with the RDS gold medal for enterprise for outstanding leadership.